Plain-English translation of NCT04088370 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at Cleveland Clinic want to understand how heavy alcohol use damages the body's immune system, particularly in people with alcoholic hepatitis (liver inflammation caused by drinking). This study will collect a single blood sample from three groups — healthy volunteers, people who drink heavily but have no liver disease, and people with alcoholic hepatitis — to compare how their immune cells respond differently to alcohol.
Alcoholic hepatitis can be life-threatening, and doctors know that alcohol triggers harmful inflammation and damages cells' energy-producing structures (called mitochondria). However, very few studies have looked closely at how this damage happens in immune cells, so this research aims to fill that gap and may lead to new treatments.
You likely qualify if…
You likely don't qualify if…
Your participation is simple: you will donate about 50 milliliters (roughly 3 tablespoons) of blood in a single visit. Researchers will then analyze your blood cells to understand how they respond to alcohol and measure things like inflammation markers, energy production in cells, and how your body processes fat and sugar. The entire process takes just one visit and poses minimal risk.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States